Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 673.50
Bid: 674.50
Ask: 675.00
Change: -2.00 (-0.30%)
Spread: 0.50 (0.074%)
Open: 676.00
High: 676.00
Low: 669.50
Prev. Close: 675.50
TATE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

8 Feb 2018 07:00

8 February 2018 – Tate & Lyle PLC

TRADING STATEMENT

Tate & Lyle issues the following trading statement for the three months ended 31 December 2017.

The Group saw volume momentum in its Speciality Food Ingredients and Bulk Ingredients divisions and remains on track to deliver progress in adjusted profit before tax in constant currency for the year ending 31 March 2018, in line with guidance.

In Speciality Food Ingredients, the core business delivered good volume growth, including a continuation of modest volume growth in North America. In Food Systems, profit improved although volume was lower. SPLENDA ® Sucralose performed as anticipated with profit in line with the comparative period. In the division overall, decisions taken in the first half, particularly to invest behind the longer term development of the business, will moderate profit growth in the second half.

In Bulk Ingredients, sweetener volume in North America grew and profit growth is currently expected to be robust for the financial year ending 31 March 2018. The 2018 calendar year bulk sweetener pricing round is now substantially complete with margins broadly in line with the previous year.

END

A conference call will be held today at 08.00am GMT, hosted by Javed Ahmed, Chief Executive and Nick Hampton, Chief Executive designate and Chief Financial Officer. Participants are requested to dial in at least 10 minutes before the commencement of the call. Dial in details are as follows:

Standard International Access: +44 (0) 20 3003 2666

Password: Tate & Lyle

A replay of this call will be available after the end of the live call for 14 days until 22 February 2018.

UK replay number: 0208 196 1998

Replay access PIN: 6346734

For more information contact Tate & Lyle PLC:

Christopher Marsh, Group VP, Investor and Media Relations

Tel: +44 (0) 20 7257 2110 or Mobile: +44 (0) 7796 192 688

Andrew Lorenz (FTI Consulting), Media Relations

Tel: +44 (0) 203 727 1323 or Mobile: +44 (0) 7775 641 807

About Tate & Lyle:

Tate & Lyle is a global provider of ingredients and solutions to the food, beverage and other industries, with operations at more than 30 facilities worldwide.

Tate & Lyle operates through two global divisions, Speciality Food Ingredients and Bulk Ingredients, supported by our Innovation and Commercial Development and Global Operations groups. The Group's strategy is to become a leading global provider of Speciality Food Ingredients through a disciplined focus on growth, and by driving Bulk Ingredients for sustained cash generation to fuel this growth.

Speciality Food Ingredients consists of three platforms: Texturants, which includes speciality starches and stabilisers; Sweeteners, which comprises nutritive sweeteners and our range of no-calorie sweeteners including SPLENDA ® Sucralose; and our Health and Wellness portfolio which includes speciality fibres and our salt-reduction offering. Additionally, our Food Systems business provides a wide variety of blended ingredient solutions.

Tate & Lyle Bulk Ingredients includes bulk sweeteners, industrial starches and fermentation products (primarily acidulants). Corn co-products from both divisions are primarily sold as animal feed.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2017, Tate & Lyle sales totalled £2.8 billion. For more information, please visit http://www.tateandlyle.com .

SPLENDA ® is a trademark of Heartland Consumer Products LLC.

View source version on businesswire.com: http://www.businesswire.com/news/home/20180207005974/en/

Copyright Business Wire 2018

Date   Source Headline
15th Nov 20121:00 pmBUSDirectorate Change
14th Nov 20124:53 pmBUSDirector/PDMR Shareholding
8th Nov 20127:01 amBUSNew Venture Fund
8th Nov 20127:00 amBUSHalf-yearly Report
1st Nov 20129:42 amBUSTotal Voting Rights
15th Oct 20124:33 pmBUSHolding(s) in Company
9th Oct 201211:21 amBUSHolding(s) in Company
4th Oct 201211:16 amBUSHolding(s) in Company
2nd Oct 20125:08 pmBUSTransaction in Own Shares
2nd Oct 201211:02 amBUSHolding(s) in Company
1st Oct 20129:14 amBUSTotal Voting Rights
28th Sep 20124:53 pmBUSTransaction in Own Shares
27th Sep 20127:00 amBUSTrading Statement
25th Sep 20125:23 pmBUSTransaction in Own Shares
12th Sep 20125:09 pmBUSTransaction in Own Shares
5th Sep 201210:57 amBUSDirector/PDMR Shareholding
3rd Sep 20129:37 amBUSTotal Voting Rights
28th Aug 20125:28 pmBUSTransaction in Own Shares
14th Aug 201210:42 amBUSDirector/PDMR Shareholding
13th Aug 20125:19 pmBUSTransaction in Own Shares
8th Aug 20125:30 pmBUSTransaction in Own Shares
7th Aug 20124:57 pmBUSDirector/PDMR Shareholding
1st Aug 201210:00 amBUSTotal Voting Rights
30th Jul 20125:10 pmBUSTransaction in Own Shares
27th Jul 20124:53 pmBUSTransaction in Own Shares
26th Jul 20124:26 pmBUSResult of AGM
26th Jul 20122:57 pmBUSDirector Declaration
26th Jul 20127:00 amBUSInterim Management Statement
25th Jul 20124:01 pmBUSCompany Secretary Change
16th Jul 20124:59 pmBUSTransaction in Own Shares
12th Jul 20123:11 pmBUSDirector/PDMR Shareholding
11th Jul 20125:05 pmBUSTransaction in Own Shares
10th Jul 20125:33 pmBUSTransaction in Own Shares
9th Jul 20125:31 pmBUSTransaction in Own Shares
6th Jul 20125:00 pmBUSTransaction in Own Shares
5th Jul 20125:10 pmBUSTransaction in Own Shares
4th Jul 20125:06 pmBUSTransaction in Own Shares
3rd Jul 20125:32 pmBUSTransaction in Own Shares
3rd Jul 20125:14 pmBUSHolding(s) in Company
2nd Jul 20125:52 pmBUSTransaction in Own Shares
2nd Jul 201211:16 amBUSTotal Voting Rights
2nd Jul 201210:43 amBUSBlocklisting Interim Review
29th Jun 20125:46 pmBUSTransaction in Own Shares
27th Jun 20127:00 amBUSDISPUTE WITH WHITEFOX TECHNOLOGIES - TRIAL RESULT
26th Jun 20124:44 pmBUSTransaction in Own Shares
22nd Jun 20129:10 amBUSDirector/PDMR Shareholding
22nd Jun 20127:10 amBUSTransaction in Own Shares
21st Jun 20123:40 pmBUSAnnual Financial Report
21st Jun 20129:45 amBUSDirector/PDMR Shareholding
20th Jun 20126:15 pmBUSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.